医院模板

  • HOME
  • | /
  • ABOUT
    • Overview
    • Team
    • Board of Directors
    • Scientific Advisory Board
    • Investors
    • Collaborators
  • | /
  • R&D
    • TNP-2092 IV
    • TNP-2092 PO
    • TNP-2198 PO
    • TNP-2092 Topical
    • CRAB
    • NTM
  • | /
  • NEWS
    • Company News
    • Publications
    • Industry News
  • | /
  • JOIN US
    • Activities
    • Job Openings
  • | /
  • CONTACT
  • 中文
  • EN

Publications

TenNor and Mayo Clinic Researchers Publish Article on Biofilm Bactericidal Activity of TNP-2092

2020-08-03
TenNor and Mayo Clinic Researchers Publish Article on Biofilm Bactericidal Activity of TNP-2092 against Biofilms Formed ...

TenNor Publishes Article on Synergistic Activity of Oxazolidinone-Nitroimidazole Conjugates

2020-05-25
The introductions of the bicyclic 4‐nitroimidazole and the oxazolidinone classes of antimicrobial agents represented the...

TenNor publishes article on TNP-2092 PO Potential Application in the Treatment of Gastrointestinal

2019-12-20
TenNor publishes article on TNP-2092 PO Potential Application in the Treatment of Gastrointestinal and Liver Disorders i...

TenNor’s Publication on TNP-2092 was Selected as ACS Editors’ Choice

2016-08-11
TenNor’s article “Development of a Dual-Acting Antibacterial Agent (TNP-2092) for the Treatment of Persistent Bacterial ...
more

ABOUT

Overview

Team

Board of Directors

Scientific Advisory Board

Investors

Collaborators

R&D

TNP-2092 IV

TNP-2092 PO

TNP-2198 PO

TNP-2092 Topical

CRAB

NTM


NEWS

Company News

Publications

Industry News

JOIN US

Activities

Job Openings

 

CONTACT


©2013 TENNOR THERAPEUTICS LTD

电话咨询：020-000000
QQ咨询：258506508
微信客服
扫码咨询